Immobilisation hypercalciuria after limb fractures in children

Area of Science:

• Pediatric Endocrinology
• Nephrology
• Metabolic Bone Disease

Background:

• Immobilization in children, often due to fractures or paralysis, frequently leads to hypercalciuria (elevated urine calcium) and hypercalcemia (elevated blood calcium).
• These metabolic disturbances increase the risk of kidney stone formation (nephrolithiasis) in affected pediatric patients.
• Monitoring calcium metabolism is crucial for children experiencing prolonged immobility.

Purpose of the Study:

• To evaluate the efficacy of hydrochlorothiazide (HCT) in preventing renal stones in pediatric patients with immobilization-induced hypercalciuria.
• To investigate the mechanisms by which HCT exerts its protective effect against stone formation.

Main Methods:

• The study likely involved assessing calcium metabolism in children with immobilization.
• Treatment with hydrochlorothiazide (HCT) was administered to a cohort of these children.
• Urine calcium concentration and crystalluria were monitored before and after HCT administration.

Main Results:

• Hydrochlorothiazide (HCT) demonstrated a beneficial effect in preventing renal stones.
• HCT significantly reduced urinary calcium concentration.
• A notable decrease in crystalluria was observed with HCT treatment.

Conclusions:

• Hydrochlorothiazide (HCT) is recommended for pediatric patients suffering from hypercalciuria associated with prolonged immobilization, particularly after fracture treatment or paralysis.
• The primary mechanism of HCT's benefit involves lowering urine calcium levels and reducing crystal formation.
• Early assessment and management of calcium metabolism are vital in immobilized children to prevent nephrolithiasis.